Bos Asset Management, LLC Bristol Myers Squibb CO Transaction History

Bos Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $86,364 - $97,920	-1,800 Reduced 27.95%	4,640 $252 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $36,360 - $43,387	-750 Reduced 10.43%	6,440 $330 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $18,987 - $21,231	-328 Reduced 4.36%	7,190 $417 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $19,712 - $22,359	-300 Reduced 3.84%	7,518 $521 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $535,376 - $633,961	7,818 New	7,818 $563 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bos Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bos Asset Management, LLC with notifications on news.